TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.50$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MNKD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1,500.7% +24.7% -57.1%
-28.5% -68.7% -15.2% -51.8% +26.7% +54.4% +64.6% +14.9% -7.7% +55.8% +35.9%
-82.1% -41.1% -5.6% +41.5% -9.5% +5.0% +87.4% +10.2% +31.2% +21.0% +13.3%
+139.4% -159.0% -75.6% -83.4% +3,404.4% -18.3% -56.3%
-69.4% -440.0% +33.0% -133.7% -349.4%
-57.3% -88.9% +0.0% -69.1% +624.6% +86.5% +139.7% -33.8% +459.2% -77.2% -52.9%
-57.7% -89.0% -101.4% +9,662.0% -1,095.9% -140.8% +4,761.6% +215.4%
+2,167.2% -96.7%
-93.1% -91.1% -23.0% -99.0% +4.3% -172.8% -152.4%
-262.8% -92.3% -142.8% -76.7% +1,094.7% -100.0% +36,938.9% +1,897.4%
-91.9% +659.3% +70.9% -16.7% +14.0% -28.6% +442.1% -92.1% +538.2% -200.5%
-223.4% -8.4% -277.7% +54.4% -195.4% -213.4%
-58.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?